Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States

被引:213
作者
Coque, TM
Tomayko, JF
Ricke, SC
Okhyusen, PC
Murray, BE
机构
[1] UNIV TEXAS,SCH MED,DIV INFECT DIS,DEPT INTERNAL MED,HOUSTON,TX 77030
[2] UNIV TEXAS,SCH MED,CTR STUDY EMERGING & REEMERGING PATHOGENS,HOUSTON,TX 77030
[3] UNIV TEXAS,SCH MED,DEPT MICROBIOL & MOL GENET,HOUSTON,TX 77030
[4] TEXAS A&M UNIV,DEPT POULTRY SCI,COLLEGE STN,TX 77843
关键词
D O I
10.1128/AAC.40.11.2605
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The presence of vancomycin-resistant enterococci (VRE) was looked for in fecal samples from 104 healthy volunteers (3 with hospital exposure), 100 selected hospitalized patients, and various environmental sources (44 commercial chickens, 5 farm-raised chickens, 3 turkeys, and 2 chicken farm lagoon slurries). Five probiotic preparations were also studied. No VRE with vanA or vanB genes were isolated from the healthy volunteers without hospital exposure, environmental sources, or probiotic preparations. VRE with vanB were found in the stools of 16% of the high-risk hospitalized patients and in one volunteer with hospital contact. All VRE examined could be classified into one of two clones by pulsed-field gel electrophoresis. VRE from 11 of the colonized patients were quantified and ranged from 10(3) to 10(6) CFU/g of stool. This study, in contrast to findings in Europe, failed to find evidence of VanA- or VanB-type VRE in the community or environmental sources in Houston, Texas, and suggests that these settings are not a likely source of VRE in hospitals in this geographic area.
引用
收藏
页码:2605 / 2609
页数:5
相关论文
共 51 条
[11]   IDENTIFICATION OF ENTEROCOCCUS-FAECALIS STRAINS BY DNA HYBRIDIZATION AND PULSED-FIELD GEL-ELECTROPHORESIS [J].
COQUE, TM ;
MURRAY, BE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3368-3369
[12]   CHARACTERIZATION OF THE CHROMOSOMAL AAC(6')-II GENE-SPECIFIC FOR ENTEROCOCCUS-FAECIUM [J].
COSTA, Y ;
GALIMAND, M ;
LECLERCQ, R ;
DUVAL, J ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1896-1903
[13]  
*CTR DIS CONTR PRE, 1993, MMWR-MORBID MORTAL W, V42, P597
[14]  
Dunne WM, 1996, ASM NEWS, V62, P283
[15]   EMERGENCE OF HIGH-LEVEL RESISTANCE TO GLYCOPEPTIDES IN ENTEROCOCCUS-GALLINARUM AND ENTEROCOCCUS-CASSELIFLAVUS [J].
DUTKAMALEN, S ;
BLAIMONT, B ;
WAUTERS, G ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1675-1677
[16]   THE VANA GLYCOPEPTIDE RESISTANCE PROTEIN IS RELATED TO D-ALANYL-D-ALANINE LIGASE CELL-WALL BIOSYNTHESIS ENZYMES [J].
DUTKAMALEN, S ;
MOLINAS, C ;
ARTHUR, M ;
COURVALIN, P .
MOLECULAR AND GENERAL GENETICS, 1990, 224 (03) :364-372
[17]   SEQUENCE OF THE VANC GENE OF ENTEROCOCCUS-GALLINARUM BM4174 ENCODING A D-ALANINE - D-ALANINE LIGASE-RELATED PROTEIN NECESSARY FOR VANCOMYCIN RESISTANCE [J].
DUTKAMALEN, S ;
MOLINAS, C ;
ARTHUR, M ;
COURVALIN, P .
GENE, 1992, 112 (01) :53-58
[18]   THE VANB GENE OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS V583 IS STRUCTURALLY RELATED TO GENES ENCODING D-ALA D-ALA LIGASES AND GLYCOPEPTIDE-RESISTANCE PROTEINS VANA AND VANC [J].
EVERS, S ;
SAHM, DF ;
COURVALIN, P .
GENE, 1993, 124 (01) :143-144
[19]  
Facklam Richard R., 1995, P308
[20]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-DURANS [J].
HALL, LMC ;
CHEN, HY ;
WILLIAMS, RJ .
LANCET, 1992, 340 (8827) :1105-1105